Filtros de búsqueda

Lista de obras de Mikael Rinne

A prognostic cytogenetic scoring system to guide the adjuvant management of patients with atypical meningioma

artículo científico publicado en 2015

A randomized, placebo-controlled pilot trial of armodafinil for fatigue in patients with gliomas undergoing radiotherapy

artículo científico publicado en 2016

ACTR-93. A PHASE I STUDY OF MLN0128 (TAK-228) AND BEVACIZUMAB IN PATIENTS WITH ADVANCED SOLID TUMORS INCLUDING GLIOBLASTOMA

AT-36PANOBINOSTAT IN COMBINATION WITH BEVACIZUMAB FOR RECURRENT GLIOBLASTOMA AND ANAPLASTIC GLIOMA

ATNT-18A PHASE I STUDY OF MLN0128 AND BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA AND OTHER SOLID TUMORS.

artículo científico publicado en 2015

Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningioma

artículo científico publicado en 2014

An Approach to Realizing Process Control for Underground Mining Operations of Mobile Machines

artículo científico publicado en 2015

Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II Trial

scientific article published on 04 February 2019

Central nervous system complications of cancer therapy

artículo científico publicado en 2012

Clinical implementation of integrated whole-genome copy number and mutation profiling for glioblastoma

artículo científico publicado en 2015

Extent of resection and overall survival for patients with atypical and malignant meningioma

artículo científico publicado en 2015

HOUT-28. OFF-LABEL USE OF PD-1 BLOCKADE WITH OR WITHOUT BEVACIZUMAB CONFERS ONLY LIMITED CLINICAL BENEFIT IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMA

Individualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT): A Bayesian Adaptive Platform Trial to Develop Precision Medicines for Patients With Glioblastoma

scientific article published on 27 March 2019

Intelligent Scheduling for Underground Mobile Mining Equipment

artículo científico publicado en 2015

MNGO-01A PROGNOSTIC CYTOGENETIC SCORING SYSTEM TO GUIDE THE ADJUVANT MANAGEMENT OF PATIENTS WITH ATYPICAL MENINGIOMA.

artículo científico publicado en 2015

PD-1 inhibition has only limited clinical benefit in patients with recurrent high-grade glioma

artículo científico publicado en 2018

PHASE II TRIAL OF THE PHOSPHATIDYINOSITOL-3 KINASE (PI3K) INHIBITOR BUPARLISIB (BKM120) IN RECURRENT GLIOBLASTOMA CONDUCTED BY THE IVY FOUNDATION EARLY PHASE CLINICAL TRIALS CONSORTIUM.

artículo científico publicado en 2014

Phase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic glioma

artículo científico publicado en 2015

Phase II trial of triple tyrosine kinase receptor inhibitor nintedanib in recurrent high-grade gliomas.

artículo científico publicado en 2014

Retrospective study of carmustine or lomustine with bevacizumab in recurrent glioblastoma patients who have failed prior bevacizumab

artículo científico publicado en 2014

SM-03A RANDOMIZED, PLACEBO-CONTROLLED PILOT TRIAL OF ARMODAFINIL FOR FATIGUE IN PATIENTS WITH GLIOMAS UNDERGOING RADIOTHERAPY.

artículo científico publicado en 2014

Update on bevacizumab and other angiogenesis inhibitors for brain cancer

artículo científico

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda